Macrophage Migration Inhibitory Factor (MIF) Interacts with Bim and Inhibits Bim-mediated Apoptosis |
Liu, Lingfeng
(State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University)
Chen, Jinzhong (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Ji, Chaoneng (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Zhang, Jiayi (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Sun, Junlei (Department of Biochemistry and Molecular Biology, 108 Althouse Laboratory, The Pennsylvania State University) Li, Yao (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Xie, Yi (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Gu, Shaohua (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) Mao, Yumin (State Key Laboratory of Genetic Engineering, Institute of Genetics, School of Life Sciences, Fudan University) |
1 | Bucala, R. (1996). MIF re-discovered: pituitary hormone and glucocorticoid- induced regulator of cytokine production. FASEB J. 7, 19-24. |
2 | Bucala, R., and Donnelly, S.C. (2007). Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26, 281-285. DOI ScienceOn |
3 | Chen, J.Z., Ji, C.N., Gu, S.H., Li, J.X., Zhao, E.P., Huang, Y., Huang, L., Ying, K., Xie, Y., and Mao, Y.M. (2004). Overexpression of Bim alpha3, a novel isoform of human Bim, result in cell apoptosis. Int. J. Biochem. Cell Biol. 36, 1554-1561. |
4 | David, J.R. (1966). Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoidcell-antigen interaction. Proc. Natl. Acad. Sci. USA RS, 72-77. |
5 | Ewings, K.E., Wiggins, C.M., and Cook, S.J. (2007). Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 6, 2236-2240. DOI ScienceOn |
6 | Hagemann, T., Robinson, S.C., Thompson, R.G., Charles, K., Kulbe, H., and Balkwill, F.R. (2007). Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol. Cancer Ther. 6, 1993-2002. DOI ScienceOn |
7 | Harada, H., Quearry, B., Ruii-Vela, A., and Korsmeyer, S.J. (2004). Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity. Proc. Natl. Acad. Sci. USA 101, 15313- 15317. |
8 | Klein, E., Ben-Bassat, H., Neumann, H., Ralph, P., Zeuthen, J., Polliack, A., and Vánky, F. (1976). Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia. Int. J. Cancer 18, 421-431. DOI |
9 | Lei, K., and Davis, R.J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA 100, 2432-2437. |
10 | Liu, L., Chen, J., Zhang, J., Ji, C., Zhang, X., Gu, S., Xie, Y., and Mao Y. (2007). Overexpression of BimSs3, the novel isoform of Bim, can trigger cell apoptosis by inducing cytochrome c release from mitochondria. Acta Biochim. Pol. 54, 603-610. |
11 | Lubetsky, J.B., Swope, M., Dealwis, C., Blake, P., and Lolis, E. (1999). Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity. Biochemistry 38, 7346-7354. DOI ScienceOn |
12 | Verma, N.K., Singh, G., and Dey, C.S. (2007). Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction. Exp. Parasitol. 116, 1- 13. DOI ScienceOn |
13 | Rosengren, E., Aman, P., Thelin, S., Hansson, C., Ahlfors, S., Bjork, P., Jacobsson, L., and Rorsman, H. (1997). The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett. 417, 85-88. DOI ScienceOn |
14 | Talos, F., Mena, P., Fingerle-Rowson, G., Moll, U., and Petrenko, O. (2005). MIF loss impairs Myc-induced lymphomagenesis. Cell Death Differ. 12, 1319-1328. DOI ScienceOn |
15 | Ueda, S., Nakamura, H., Masutani, H., Sasada, T., Yonehara,S., Takabayashi, A., Yamaoka, Y., and Yodoi. J. (1998). Redox regulation of caspase-3(-like) protease activity: regulatory roles of thioredoxin and cytochrome c. J. Immunol. 161, 6689-6695. |
16 | Wilson, J.M., Coletta, P.L., Cuthbert, R.J., Scott, N., MacLennan, K., Hawcroft, G., Leng, L., Lubetsky, J.B., Jin, K.K., Lolis, E., et al. (2005). Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129, 1485-1503 DOI ScienceOn |
17 | Youle, R.J., and Strasser, A. (2008).The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell. Biol. 9, 47-59. DOI ScienceOn |
18 | Farr, A., DeRoos, P.C., Eastman, S., and Rudensky, A.Y. (1996). Differential expression of CLIP:MHC class II and conventional endogenous peptide:MHC class II complexes by thymic epithelial cells and peripheral antigen-presenting cells. Eur. J. Immunol. 26, 3185-3193. DOI ScienceOn |
19 | Mitchell, R.A. (2004). Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal. 16, 13-19. DOI ScienceOn |
20 | Bloom, B.R., and Bennett, B. (1966). Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 153, 80-82. DOI ScienceOn |
21 | Hermanowski-Vosatka, A., Mundt, S.S., Ayala, J.M., Goyal, S., Hanlon, W.A., Cierwinski, R.M., Wright, S.D., and Whitman, C.P. (1999). Eniymatically inactive macrophage migration inhibitory factor inhibits monocyte chemotaxis and random migration. Biochemistry 38, 12841-12949. DOI ScienceOn |
22 | Leng, L., Meti, C.N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R.A., and Bucala, R. (2003). MIF signal transduction initiated by binding to CD74. J. Exp. Med. 197, 1467-1476. DOI ScienceOn |
23 | Swope, M.D., and Lolis. E. (1999). Macrophage migration inhibitory factor: cytokine, hormone, or eniyme. Rev. Physiol. Biochem. Pharmacol. 139, 1-32. DOI |
24 | Baugh, J.A., and Bucala R. (2002). Macrophage migration inhibitory factor. Crit Care Med. 30 (Suppl. 1), S27-S35. DOI ScienceOn |
25 | Mitchell, R.A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., and Bucala, R. (2002). Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response. Proc. Natl. Acad. Sci. USA 99, 345-350. |
26 | Ren, Y., Law, S., Huang, X., Lee, P.Y., Bacher, M., Srivastava, G., and Wong, J. (2005). Macrophage migration inhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma. Ann. Surg. 242, 55-63 DOI ScienceOn |
27 | Calandra, T., Bernhagen, J., and Meti, C.N. (1995). MIF as a glucocorticoid- induced modulator of cytokine production. Nature 377, 68-71. DOI ScienceOn |
28 | Lue, H., Kleemann, R., Calandra, T., Roger, T., and Bernhagen, J. (2002). Macrophage migration inhibitory factor (MIF): mechanisms of action and role in disease. Microbes Infect. 4, 449-460. DOI ScienceOn |
29 | Kleemann, R., Kapurniotu, A., Frank, R.W., Gessner, A., Mischke, R., Flieger, O., Jüttner, S., Brunner, H., and Bernhagen, J. (1998). Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J. Mol. Biol. 280, 85-102. DOI ScienceOn |
30 | Morand, E.F. (2005). New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Intern. Med. J. 35, 419-426. DOI ScienceOn |
31 | Lue, H., Thiele, M., Frani, J., Dahl, E., Speckgens, S., Leng, L., Fingerle-Rowson, G., Bucala, R., Lüscher, B., and Bernhagen. J. (2007). Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 26, 5046-5059. DOI ScienceOn |
32 | Chen, J.Z., Ji, C.N., Xu, G.L., Pang, R.Y., Yao, J.H., Zhu, H.Z., Xue, J.L., and Jia, W. (2006). DAXX interacts with phage PhiC31 integrase and inhibits recombination. Nucleic Acids Res. 34, 6298-6304. DOI ScienceOn |
33 | Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., and Shachar, I. (2008). Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem. 283, 2784-2792. DOI ScienceOn |
34 | Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger- Kentischer, A., Flieger, O., Johannes, F.J., Roger, T., Calandra, T., Kapurniotu, A., et al. (2000b). Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Nature. 408, 211-216. DOI ScienceOn |
35 | Calandra, T., and Roger, T. (2003). Macrophage migration inhibitory factor: a regulator of innate immunity. Nat. Rev. Immunol. 3, 791-800. DOI ScienceOn |
36 | Nguyen, M.T., Lue, H., Kleemann, R., Thiele, M., Tolle, G., Finkelmeier, D., Wagner, E., Braun, A., and Bernhagen, J. (2003). The cytokine macrophage migration inhibitory factor reduces prooxidative stress-induced apoptosis. J. Immunol. 170, 3337-3347. DOI |
37 | Adachi, M., Zhao, X., and Imai, K. (2005). Nomenclature of dynein light chain-linked BH3-only protein Bim isoforms. Cell Death Differ. 12, 192-193. DOI ScienceOn |
38 | U, M., Miyashita, T., Shikama, Y., Tadokoro, K., and Yamada, M. (2001). Molecular cloning and characteriiation of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family. FEBS Lett. 509, 135-141. DOI ScienceOn |
39 | Cheng, E.H., Wei, M.C., Weiler, S., Flavell, R.A., Mak, T.W., Lindsten, T., and Korsmeyer, S.J. (2007). BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAKmediated mitochondrial apoptosis. Mol. Cell 8, 705-711. DOI ScienceOn |
40 | Li, L., Elledge, S.J., Peterson, C.A., Bales, E.S., and Legerski, R.J. (1994). Specific association between the human DNA repair proteins XPA and ERCC1. Proc. Natl. Acad. Sci. USA 91, 5012- 5016. |
41 | Swope, M., Sun, H.W., Blake, P.R., and Lolis, E. (1998). Direct link between cytokine activity and a catalytic site for macrophage migration inhibitory factor. EMBO J. 17, 3534-3541. DOI ScienceOn |
42 | Liu, L., Ji, C., Chen, J., Li, Y., Fu, X., Xie, Y., Gu, S., and Mao, Y. (2008). A global genomic view of MIF knockdown-mediated cell cycle arrest. Cell Cycle 7, 1678-1692. DOI ScienceOn |
43 | Bernhagen, J., Krohn, R., Lue, H., Gregory, J.L., Zernecke, A., Koenen, R.R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007). MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596. DOI ScienceOn |
44 | Nemajerova, A., Moll, U.M., Petrenko, O., and Fingerle-Rowson, G. (2007). Macrophage migration inhibitory factor coordinates DNA damage response with the proteasomal control of the cell cycle. Cell Cycle 6, 1030-1034. DOI ScienceOn |
45 | Puthalakath, H., Huang, D.C., O'Reilly, L.A., King, S.M., and Strasser, A. (1999). The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol. Cell 3, 287-296. DOI ScienceOn |
46 | Gross, A., McDonnell, J.M., and Korsmeyer, S.J. (1999). BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911. DOI ScienceOn |
47 | Senter, P.D., Al-Abed, Y., Meti, C.N., Benigni, F., Mitchell, R.A., Chesney, J., Han, J., Gartner, C.G., Nelson, S.D., Todaro, G.J., et al. (2002). Inhibition of macrophage migration inhibitory factor (MIF) tautomerase and biological activities by acetaminophen metabolites. Proc. Natl. Acad. Sci. USA 99, 144-149. |
48 | Onodera, S., Suiuki, K., Matsuno, T., Kaneda, K., Takagi, M., and Nishihira, J. (1997). Macrophage migration inhibitory factor induces phagocytosis of foreign particles by macrophages in autocrine and paracrine fashion. Immunology 92, 131-137. DOI |
49 | Rosengren, E., Bucala, R., Aman, P., Jacobsson, L., Odh, G., Meti, C.N., and Rorsman, H. (1996). The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyies a tautomeriiation reaction. Mol. Med. 2, 143-149. |
50 | Kleemann, R., Rorsman, H., Rosengren, E., Mischke, R., Mai, N.T., and Bernhagen, J. (2000a). Dissection of the eniymatic and immunologic functions of macrophage migration inhibitory factor. Full immunologic activity of N-terminally truncated mutants. Eur. J. Biochem. 267, 7183-7193. DOI ScienceOn |